Showing results (321-330 of 658) with videos related to
Sort By:
Pageof 66
The Lancet. Oncology|October 6, 2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialEric L Chang, Jeffrey S Wefel, Kenneth R Hess, et al.Journal of Neuro-Oncology|January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathwayKe Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial MelanomasHong Jiang, Dong Ho Shin, Teresa T Nguyen, et al.Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03Christina Tsien, Jennifer Moughan, Jeff M Michalski, et al.Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.Cancer|June 23, 2021
Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017Diana R Withrow, Susan S Devesa, Dennis Deapen, et al.Radiology|November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 StudyDaniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.Stem Cells (Dayton, Ohio)|January 10, 2012
REST regulates oncogenic properties of glioblastoma stem cellsMohamed M Kamal, Pratheesh Sathyan, Sanjay K Singh, et al.Pageof 66